Doctrine and a Hype Without a Transcript: Overwatch 2 Unveils a New Support While PTR Data Remains Empty

On the reveal night at BlizzCon 2026, when Doctrine's gameplay first played on the big screen, the crowd erupted at a double Infuse: Overwatch 2's new support healed an ally and simultaneously boosted her own movement speed to escape two shooters pinning her into a corner. Twelve seconds of footage. Four days later, I combed through every PTR patch note, scanned every official Blizzard announcement, and still could not find a single line confirming the numbers behind that ability. The emotion was already there; the transcript was not. For someone whose trade is recording every decision, that order of events is always a problem. Emotion can lean, but the replay does not. This time, the tape has not even been run in full.

Overwatch 2 is hardly short of support heroes. Since the original launched in 2026, Blizzard has added eight support slots in sequence: Ana (2026), Moira (2026), Brigitte (2026), Baptiste (2026), Kiriko (2026), Lifeweaver and Illari (2026), then Juno (2026). Every time a new support appears, team structures shift in unpredictable ways. Brigitte 2026 spawned an entire GOATS meta that forced tournaments to change their ban rules; Kiriko 2026 pushed defensive weight toward cleanse; Juno 2026 turned movement speed into a tactical resource. In other words, history has taught us that a support hero is not merely a personal pick — it is a variable capable of rewriting a whole leaderboard.

That is why those twelve seconds deserve scrutiny. Doctrine was introduced with two hallmarks: an Infuse mechanic and an accompanying Perks system. By the circulating description, Infuse lets Doctrine bank up to two charges to amplify other abilities — including healing and mobility — while her ultimate cannot be infused. Within the Perks system, the two upgrades most often mentioned are Cost of Life and Transfusion. Here my transcript goes blank: no specific cooldown per Infuse charge, no healing value, no movement-speed bonus, no shared or independent recharge timing. A two-charge ability can be a decisive weapon, or it can be an excuse for players to save too much and lose tempo. Without data, those two outcomes are equally likely.

Setting aside the unverified parts, the core design is still worth analyzing. Doctrine belongs to the vampiric support family — heroes capable of self-sustaining, reducing dependence on allies. In balance history, this is dangerous design space. Moira 2026 was placed under watch for combining self-sustain with damage; Kiriko drew controversy for cleansing, healing and teleporting at once. A support that can look after itself always stands before two paths: either it becomes the safe pick for a lone player, or it becomes a tool abused to evade pin-down pressure. The Infuse mechanic pushes Doctrine toward the second, because it rewards reading the right moment rather than demanding aim.

The key point is here: Infuse turns Doctrine from a skill hero into a resource-management hero. Players no longer only ask "who do I heal," but "which ability do I amplify, when, and how many charges do I keep in reserve for what comes next." This two-charge design appeared on Baptiste with Immortality Field, but always with a long cooldown to prevent abuse. With Doctrine, missing a specific cooldown, we cannot know whether she will freeze up from hoarding charges. Put another way, Doctrine's difficulty is not in the hands — it is in the head.

Based on my experience following professional matches, heroes that reward resource decisions tend to create an enormous gap between high and low ranks. At low ranks, players tend to burn both Infuse charges within the first thirty seconds of a fight, then stand exposed when the enemy pushes the objective. At high ranks, those two charges can be saved for exactly one ally-saving moment or one decisive escape. This is the kind of hero whose win rate always lies unless it is split by rank — and that makes any current claim that "Doctrine heals a lot" merely an opinion, not a fact.

The two mentioned Perks also deserve discussion. Cost of Life suggests a trade: giving up health or a state in exchange for a specific benefit, fitting the vampire theme. Transfusion, by its name, likely relates to transferring blood to allies or converting resources. If Cost of Life lets Doctrine convert her own blood into ally healing, it opens a playstyle of a support deliberately placing herself in danger to hold the backline. If Transfusion lets her shift blood from enemies to allies, it could flip fights in extended engagements. Both are compelling, and both lie in a zone that cannot be confirmed until the PTR opens.

One other detail stands out, and it concerns source transparency. The original article I cross-checked does not clearly state its sources, most information points carry a "no source" label, and the BlizzCon 2026 timestamp is itself a question mark about the actual timing of the event. When a product-introduction document lacks sources, I treat it as a draft, not an announcement. This is not about nitpicking anyone's honor; it is about classifying evidence. In the transcript trade, a draft is treated as a draft, however compelling its content.

So where is the contrarian angle? The community is running ahead of the data. Content channels have already built Infuse combo guides, ranked Doctrine as S-tier, even simulated ideal team compositions — all from twelve seconds of gameplay. History repeats every arena season: Lifeweaver was first dismissed as redundant, then suspected of being too strong after a few patches; Illari opened with hype then faded as the meta rotated. The counterintuitive part is that the more complex a support hero is in resource terms, the harder it is to judge on release day. The first forty-eight hours are never a good yardstick for a charge-management hero. Every play is a line in the transcript, and I write it without omission, but I only write what is on the tape.

Not to mention, Overwatch 2's Perks system has already added another layer of variables. A hero can be strong in the hands of a group running Cost of Life, yet weakened when opponents pick a plan optimized for area damage. Without an internal test build, no one can say what share of a match's total healing Transfusion will account for. Referee data is not for convicting, but for exonerating — and in Doctrine's case, the data is not yet enough to convict either those inflating her or those dismissing her.

There is a habit I have kept for years, since my first notebook: never declare right or wrong before watching in slow motion. In 2026, when I recorded every refereeing decision of a World Cup, I learned that instantaneous feeling is almost always off compared to the replayed frame. Forty-seven pages of notebook taught me one thing: stay silent when you have not seen the evidence. Applied to Doctrine, that means waiting for the PTR, waiting for rank-split win rates, waiting to see whether pro teams try her in scrims. Any conclusion born before those milestones is a guess dressed as analysis.

The next thing worth tracking is signals from the professional arena. If star supports on top teams start practicing Doctrine on stream, that is an early sign the hero will enter the competitive meta. If after a few weeks they still revert to old compositions, we will have the opposite answer. For now, the tape is still only twelve seconds long, and I will not write another line of transcript for the missing time. The open question: will the next gameplay segment Blizzard releases confirm Doctrine as a true resource support, or merely a pretty draft that has yet to acquire numbers?